555259977	555259977	CD	B-NP	O
|	|	NN	I-NP	O
HWVGH	HWVGH	NN	I-NP	O
|	|	NN	I-NP	O
04561993	04561993	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
0537302	0537302	CD	B-NP	O
|	|	CC	I-NP	O
5/26/2005	5/26/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
AORTIC	AORTIC	NNP	I-NP	I-protein
STENOSIS	STENOSIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/26/2005	5/26/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/7/2005	11/7/2005	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
INCORVAIA	INCORVAIA	NNP	B-NP	O
,	,	,	O	O
FRANKLYN	FRANKLYN	NNP	B-NP	O
MD	MD	NNP	I-NP	O
SERVICE	SERVICE	NNP	I-NP	O
:	:	:	O	O
Cardiac	Cardiac	NNP	B-NP	O
Surgery	Surgery	NNP	I-NP	O
Service	Service	NNP	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
Eric	Eric	NNP	B-NP	O
Christinsen	Christinsen	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
79-year-old	79-year-old	JJ	I-NP	O
gentleman	gentleman	NN	I-NP	O
with	with	IN	B-PP	O
extensive	extensive	JJ	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
who	who	WP	B-NP	O
has	have	VBZ	B-VP	O
previously	previously	RB	I-VP	O
undergone	undergo	VBN	I-VP	O
a	a	DT	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
bypass	bypass	IN	B-PP	O
graft	graft	NN	B-NP	B-protein
x2	x2	NN	I-NP	I-protein
.	.	.	O	O

Also	Also	RB	B-ADVP	O
,	,	,	O	O
several	several	JJ	B-NP	O
percutaneous	percutaneous	JJ	I-NP	O
transluminal	transluminal	JJ	I-NP	O
coronary	coronary	JJ	I-NP	O
angioplasties	angioplasty	NNS	I-NP	O
and	and	CC	I-NP	O
stents	stent	NNS	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
saphenous	saphenous	JJ	I-NP	O
vein	vein	NN	I-NP	O
graft	graft	NN	I-NP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
first	first	JJ	I-NP	O
diagonal	diagonal	JJ	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
in	in	IN	B-PP	O
1999	1999	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
received	receive	VBD	B-VP	O
a	a	DT	B-NP	O
stent	stent	NN	I-NP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
left	left	JJ	I-NP	O
subclavian	subclavian	NN	I-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
total	total	JJ	B-NP	O
occlusion	occlusion	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
stent	stent	JJ	I-NP	O
and	and	CC	I-NP	O
angioplasty	angioplasty	JJ	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
brachial	brachial	JJ	I-NP	O
artery	artery	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
peripheral	peripheral	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
also	also	RB	B-ADVP	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
bilateral	bilateral	JJ	I-NP	O
carotid	carotid	NN	I-NP	O
endarterectomies	endarterectomy	NNS	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
a	a	DT	B-NP	O
longstanding	longstanding	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
insulin-dependent	insulin-dependent	JJ	B-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
recently	recently	RB	B-ADVP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
experiencing	experience	VBG	I-VP	O
increasing	increase	VBG	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
dyspnea	dyspnea	NN	B-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
,	,	,	O	O
paroxysmal	paroxysmal	JJ	B-NP	O
nocturnal	nocturnal	JJ	I-NP	O
dyspnea	dyspnea	NN	I-NP	O
and	and	CC	O	O
more	more	RBR	B-NP	O
frequent	frequent	JJ	I-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
substernal	substernal	JJ	B-NP	O
chest	chest	NN	I-NP	O
pressure	pressure	NN	I-NP	O
.	.	.	O	O

Aortic	Aortic	JJ	B-NP	O
valve	valve	NN	I-NP	O
area	area	NN	I-NP	O
had	have	VBD	B-VP	O
reached	reach	VBN	I-VP	O
the	the	DT	B-NP	O
value	value	NN	I-NP	O
of	of	IN	B-PP	O
0.4	0.4	CD	B-NP	O
cm2	cm2	NN	I-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
her	her	PRP$	B-NP	O
previous	previous	JJ	I-NP	O
admission	admission	NN	I-NP	O
in	in	IN	B-PP	O
September	September	NNP	B-NP	O
2005	2005	CD	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
left	left	JJ	B-NP	O
main	main	JJ	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
three	three	CD	B-NP	O
vessels	vessel	NNS	I-NP	O
with	with	IN	B-PP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
restenosis	restenosis	NN	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
successful	successful	JJ	B-ADJP	O
stenting	stente	VBG	B-VP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
left	left	JJ	I-NP	O
main	main	JJ	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
successful	successful	JJ	I-NP	O
PTCA	PTCA	NN	I-NP	O
and	and	CC	O	O
stenting	stente	VBG	B-VP	O
two	two	CD	B-NP	O
saphenous	saphenous	JJ	I-NP	O
vein	vein	NN	I-NP	O
graft	graft	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
posterior	posterior	JJ	I-NP	O
descending	descend	VBG	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
.	.	.	O	O

Echocardiogram	Echocardiogram	NN	B-NP	O
revealed	reveal	VBD	B-VP	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
50	50	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
aortic	aortic	JJ	B-NP	O
stenosis	stenosis	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
mean	mean	JJ	I-NP	O
gradient	gradient	NN	I-NP	O
of	of	IN	B-PP	O
23	23	CD	B-NP	O
mmHg	mmHg	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
peak	peak	JJ	I-NP	O
gradient	gradient	NN	I-NP	O
of	of	IN	B-PP	O
38	38	CD	B-NP	O
mmHg	mmHg	NN	I-NP	O
,	,	,	O	O
calculated	calculate	VBN	B-VP	O
valve	valve	VBP	B-VP	O
area	area	NN	B-NP	O
of	of	IN	B-PP	O
0.8	0.8	CD	B-NP	O
cm2	cm2	NN	I-NP	O
,	,	,	O	O
trivial	trivial	JJ	B-NP	O
aortic	aortic	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
mitral	mitral	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
moderate	moderate	JJ	B-NP	O
tricuspid	tricuspid	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY/PAST	HISTORY/PAST	NNP	I-NP	O
SURGICAL	SURGICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Significant	Significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
myocardial	myocardial	JJ	B-NP	O
infarction	infarction	NN	I-NP	O
in	in	IN	B-PP	O
1999	1999	CD	B-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
class	class	NN	B-NP	O
IV	IV	CD	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
with	with	IN	B-PP	O
inability	inability	NN	B-NP	O
to	to	TO	B-VP	O
carry	carry	VB	I-VP	O
on	on	IN	B-PP	O
any	any	DT	B-NP	O
physical	physical	JJ	I-NP	O
activity	activity	NN	I-NP	O
,	,	,	O	O
recent	recent	JJ	B-NP	O
signs	sign	NNS	I-NP	O
and	and	CC	I-NP	O
symptoms	symptom	NNS	I-NP	O
of	of	IN	B-PP	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
including	include	VBG	B-PP	O
paroxysmal	paroxysmal	JJ	B-NP	O
nocturnal	nocturnal	JJ	I-NP	O
dyspnea	dyspnea	NN	I-NP	O
,	,	,	O	O
dyspnea	dyspnea	NN	B-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
,	,	,	O	O
pulmonary	pulmonary	JJ	B-NP	O
edema	edema	NN	I-NP	O
on	on	IN	B-PP	O
chest	chest	NN	B-NP	O
x-ray	x-ray	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
pedal	pedal	JJ	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
status	status	NN	B-NP	O
post	post	IN	B-PP	O
a	a	DT	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
bypass	bypass	IN	B-PP	O
graft	graft	NN	B-NP	B-protein
x4	x4	NN	I-NP	I-protein
in	in	IN	B-PP	O
1989	1989	CD	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
internal	internal	JJ	I-NP	O
mammary	mammary	JJ	I-NP	O
artery	artery	NN	I-NP	O
to	to	TO	B-VP	O
left	left	VB	I-VP	O
anterior	anterior	RB	B-ADVP	O
descending	descend	VBG	B-VP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
,	,	,	O	O
saphenous	saphenous	JJ	B-NP	O
vein	vein	NN	I-NP	O
graft	graft	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
diagonal	diagonal	JJ	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
,	,	,	O	O
saphenous	saphenous	JJ	B-NP	O
vein	vein	NN	I-NP	O
graft	graft	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
posterior	posterior	JJ	I-NP	O
descending	descend	VBG	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
,	,	,	O	O
saphenous	saphenous	JJ	B-NP	O
vein	vein	NN	I-NP	O
graft	graft	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
third	third	JJ	I-NP	O
obtuse	obtuse	NN	I-NP	O
marginal	marginal	JJ	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
and	and	CC	O	O
also	also	RB	B-ADVP	O
reoperation	reoperation	NN	B-NP	O
in	in	IN	B-PP	O
1992	1992	CD	B-NP	O
for	for	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
bypass	bypass	IN	B-PP	O
graft	graft	NN	B-NP	B-protein
x2	x2	NN	I-NP	I-protein
with	with	IN	B-PP	O
a	a	DT	B-NP	O
saphenous	saphenous	JJ	I-NP	O
vein	vein	NN	I-NP	O
graft	graft	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
posterior	posterior	JJ	I-NP	O
descending	descend	VBG	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
saphenous	saphenous	JJ	B-NP	O
vein	vein	NN	I-NP	O
graft	graft	NN	I-NP	O
to	to	TO	B-VP	O
left	left	VB	I-VP	O
circumflex	circumflex	NN	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
also	also	RB	B-ADVP	O
status	status	NN	B-NP	O
post	post	VBD	B-VP	O
a	a	DT	B-NP	O
PTCA	PTCA	NN	I-NP	B-protein
and	and	CC	I-NP	O
atherectomy	atherectomy	NN	I-NP	O
in	in	IN	B-PP	O
1996	1996	CD	B-NP	O
and	and	CC	I-NP	O
1997	1997	CD	I-NP	O
and	and	CC	O	O
stent	stent	JJ	B-NP	O
placement	placement	NN	I-NP	O
in	in	IN	B-PP	O
1999	1999	CD	B-NP	O
and	and	CC	O	O
most	most	RBS	B-ADVP	O
recently	recently	RB	I-ADVP	O
as	as	IN	B-SBAR	O
stated	state	VBN	B-VP	O
above	above	IN	B-PP	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
peripheral	peripheral	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
claudication	claudication	NN	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
with	with	IN	B-PP	O
insulin-dependent	insulin-dependent	JJ	B-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
also	also	RB	B-ADVP	O
status	status	NN	B-NP	O
post	post	VBD	B-VP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
fem-pop	fem-pop	JJ	I-NP	O
bypass	bypass	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
dyslipidemia	dyslipidemia	NN	B-NP	O
,	,	,	O	O
renal	renal	JJ	B-NP	O
failure	failure	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
left	leave	VBD	B-VP	O
carotid	carotid	NN	B-NP	O
endarterectomy	endarterectomy	NN	I-NP	O
and	and	CC	O	O
right	right	JJ	B-NP	O
carotid	carotid	NN	I-NP	O
endarterectomy	endarterectomy	NN	I-NP	O
,	,	,	O	O
peripheral	peripheral	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
angioplasty	angioplasty	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
subclavian	subclavian	NN	I-NP	O
and	and	CC	O	O
left	leave	VBD	B-VP	O
brachial	brachial	JJ	B-NP	O
arteries	artery	NNS	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
peripheral	peripheral	JJ	I-NP	O
vascular	vascular	JJ	I-NP	O
stent	stent	JJ	I-NP	O
placement	placement	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
subclavian	subclavian	NN	I-NP	O
and	and	CC	O	O
left	leave	VBD	B-VP	O
brachial	brachial	JJ	B-NP	O
arteries	artery	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
status	status	NN	B-NP	O
post	post	IN	B-PP	O
a	a	DT	B-NP	O
cholecystectomy	cholecystectomy	NN	I-NP	O
and	and	CC	I-NP	O
hernia	hernia	NN	I-NP	O
repair	repair	NN	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
allergies	allergy	NNS	B-NP	O
to	to	TO	B-PP	O
Quinaglute	Quinaglute	NNP	B-NP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
,	,	,	O	O
verapamil	verapamil	NN	B-NP	O
,	,	,	O	O
where	where	WRB	B-ADVP	O
he	he	PRP	B-NP	O
develops	develop	VBZ	B-VP	O
GI	GI	NN	B-NP	O
upset	upset	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
TRANSFER	TRANSFER	NN	I-NP	O
:	:	:	O	O
Atenolol	Atenolol	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
amlodipine	amlodipine	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
losartan	losartan	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
baby	baby	NN	B-NP	O
aspirin	aspirin	NN	I-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Plavix	Plavix	NN	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Coumadin	Coumadin	NNP	B-NP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
atorvastatin	atorvastatin	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Actos	Actos	NNP	B-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Mucomyst	Mucomyst	NN	B-NP	O
,	,	,	O	O
colchicine	colchicine	NN	B-NP	O
0.6	0.6	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
insulin	insulin	NN	B-NP	O
NPH	NPH	NN	I-NP	O
Humulin	Humulin	NN	I-NP	O
25	25	CD	B-NP	O
units	unit	NNS	I-NP	O
and	and	CC	O	O
8	8	CD	B-NP	O
units	unit	NNS	I-NP	O
and	and	CC	O	O
regular	regular	JJ	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
,	,	,	O	O
Humulin	Humulin	NN	B-NP	O
of	of	IN	B-PP	O
4	4	CD	B-NP	O
units	unit	NNS	I-NP	O
,	,	,	O	O
Proscar	Proscar	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
potassium	potassium	NN	B-NP	O
chloride	chloride	NN	I-NP	O
slow	slow	JJ	I-NP	O
release	release	NN	I-NP	O
20	20	CD	I-NP	O
mEq	mEq	NN	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Cardiac	Cardiac	JJ	B-NP	O
exam	exam	NN	I-NP	O
:	:	:	O	O
Irregularly	Irregularly	RB	B-NP	O
irregular	irregular	JJ	I-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

Peripheral	Peripheral	JJ	B-NP	B-protein
vascular	vascular	JJ	I-NP	I-protein
2	2	CD	I-NP	I-protein
+	+	SYM	I-NP	O
pulses	pulse	NNS	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
carotid	carotid	NN	I-NP	O
,	,	,	O	O
radial	radial	JJ	B-NP	O
pulses	pulse	NNS	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
+	+	SYM	B-NP	O
left	leave	VBD	B-VP	O
femoral	femoral	JJ	B-NP	O
,	,	,	I-NP	O
nonpalpable	nonpalpable	JJ	I-NP	O
right	right	JJ	I-NP	O
femoral	femoral	JJ	I-NP	O
and	and	CC	I-NP	O
nonpalpable	nonpalpable	JJ	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
dorsalis	dorsalis	NN	I-NP	O
pedis	pedis	NN	I-NP	O
and	and	CC	O	O
posterior	posterior	JJ	B-NP	O
tibialis	tibialis	NN	I-NP	O
pulses	pulse	NNS	I-NP	O
.	.	.	O	O

Respiratory	Respiratory	NNP	B-NP	O
:	:	:	O	O
Breath	Breath	NNP	B-NP	O
sounds	sound	VBZ	B-VP	O
clear	clear	JJ	B-ADJP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
:	:	:	O	O
3	3	CD	B-NP	O
+	+	SYM	I-NP	O
edema	edema	NN	I-NP	O
on	on	IN	B-PP	O
both	both	DT	B-NP	O
legs	leg	NNS	I-NP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
otherwise	otherwise	RB	B-ADJP	O
noncontributory	noncontributory	JJ	I-ADJP	O
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
LABORATORY	LABORATORY	NN	I-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
Sodium	Sodium	NN	B-NP	O
of	of	IN	B-PP	O
141	141	CD	B-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
3.7	3.7	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
of	of	IN	B-PP	O
106	106	CD	B-NP	O
,	,	,	O	O
CO2	CO2	NN	B-NP	O
29	29	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	O
of	of	IN	B-PP	O
45	45	CD	B-NP	O
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
1.5	1.5	CD	I-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	O
of	of	IN	B-PP	O
88	88	CD	B-NP	O
,	,	,	O	O
magnesium	magnesium	NN	B-NP	O
1.9	1.9	CD	I-NP	O
.	.	.	O	O

WBC	WBC	NNP	B-NP	O
6.02	6.02	CD	I-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
27.2	27.2	CD	I-NP	I-protein
,	,	,	O	O
hemoglobin	hemoglobin	NN	B-NP	B-protein
8.4	8.4	CD	I-NP	I-protein
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-cell_type
of	of	IN	B-PP	O
239	239	CD	B-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
.	.	.	O	O

PT	PT	NN	B-NP	O
of	of	IN	B-PP	O
36	36	CD	B-NP	O
and	and	CC	O	O
PT/INR	PT/INR	NN	B-NP	B-protein
of	of	IN	B-PP	O
3.6	3.6	CD	B-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
Alex	Alex	NNP	B-NP	O
Chumley	Chumley	NNP	I-NP	O
was	be	VBD	B-VP	O
brought	bring	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
operating	operating	NN	I-NP	O
room	room	NN	I-NP	O
on	on	IN	B-PP	O
1/14/05	1/14/05	CD	B-NP	O
where	where	WRB	B-ADVP	O
he	he	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
an	an	DT	B-NP	O
elective	elective	JJ	I-NP	O
reoperation	reoperation	NN	I-NP	O
aortic	aortic	JJ	I-NP	O
valve	valve	NN	I-NP	O
replacement	replacement	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
23	23	CD	I-NP	O
mm	mm	NN	I-NP	O
Mosaic	Mosaic	JJ	I-NP	O
valve	valve	NN	I-NP	O
.	.	.	O	O

Total	Total	JJ	B-NP	O
bypass	bypass	NN	I-NP	O
time	time	NN	I-NP	O
was	be	VBD	B-VP	O
119	119	CD	B-NP	O
minutes	minute	NNS	I-NP	O
,	,	,	O	O
total	total	JJ	B-NP	O
crossclamp	crossclamp	NN	I-NP	O
time	time	NN	I-NP	O
was	be	VBD	B-VP	O
69	69	CD	B-NP	O
minutes	minute	NNS	I-NP	O
.	.	.	O	O

Intraoperatively	Intraoperatively	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
cannulated	cannulate	VBN	I-VP	O
via	via	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
axillary	axillary	JJ	I-NP	O
artery	artery	NN	I-NP	O
and	and	CC	O	O
left	leave	VBD	B-VP	O
femoral	femoral	JJ	B-NP	O
vein	vein	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
sternotomy	sternotomy	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
while	while	IN	B-SBAR	O
on	on	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
bypass	bypass	NN	I-NP	O
without	without	IN	B-PP	O
incident	incident	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
trileaflet	trileaflet	NN	I-NP	O
calcified	calcify	VBD	B-VP	O
aortic	aortic	JJ	B-NP	O
valve	valve	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
excised	excise	VBN	I-VP	O
after	after	IN	B-PP	O
transverse	transverse	JJ	B-NP	O
aortotomy	aortotomy	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
well	well	RB	B-ADVP	O
intraoperatively	intraoperatively	RB	I-ADVP	O
,	,	,	O	O
came	come	VBD	B-VP	O
off	off	RP	B-PRT	O
bypass	bypass	NN	B-NP	O
without	without	IN	B-PP	O
incident	incident	NN	B-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
brought	bring	VBN	I-VP	O
up	up	RP	B-PRT	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Intensive	Intensive	JJ	I-NP	O
Care	Care	NNP	I-NP	O
Unit	Unit	NNP	I-NP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
and	and	CC	O	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
.	.	.	O	O

Postoperatively	Postoperatively	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
very	very	RB	B-ADVP	O
well	well	RB	I-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
extubated	extubate	VBN	I-VP	O
and	and	CC	O	O
transferred	transfer	VBN	B-VP	O
to	to	TO	B-PP	O
Step-Down	Step-Down	NNP	B-NP	O
Unit	Unit	NNP	I-NP	O
on	on	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	B-protein
day	day	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
1	1	CD	I-NP	I-protein
.	.	.	O	O

He	He	PRP	B-NP	O
did	do	VBD	B-VP	O
receive	receive	VB	I-VP	O
transfusion	transfusion	NN	B-NP	O
of	of	IN	B-PP	O
2	2	CD	B-NP	O
units	unit	NNS	I-NP	O
packed	pack	VBD	B-VP	O
red	red	JJ	B-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
for	for	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
anemia	anemia	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
Plavix	Plavix	NN	I-NP	O
,	,	,	I-NP	O
aspirin	aspirin	NN	I-NP	O
and	and	CC	I-NP	O
Coumadin	Coumadin	NN	I-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
for	for	IN	B-PP	O
his	his	PRP$	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
.	.	.	O	O

Heath	Heath	NNP	B-NP	O
Uren	Uren	NNP	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
an	an	DT	B-NP	O
air	air	NN	I-NP	O
leak	leak	NN	I-NP	O
from	from	IN	B-PP	O
his	his	PRP$	B-NP	O
chest	chest	NN	I-NP	O
tube	tube	NN	I-NP	O
and	and	CC	O	O
also	also	RB	B-VP	O
did	do	VBD	I-VP	O
begin	begin	VB	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
some	some	DT	B-NP	O
postoperative	postoperative	JJ	I-NP	O
confusion	confusion	NN	I-NP	O
on	on	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	B-protein
day	day	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

His	His	PRP$	B-NP	O
narcotics	narcotic	NNS	I-NP	O
were	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
.	.	.	O	O

His	His	PRP$	B-NP	B-protein
chest	ch	JJS	I-NP	O
tube	tube	NN	I-NP	O
air	air	NN	I-NP	O
leak	leak	NN	I-NP	O
resolved	resolve	VBD	B-VP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
chest	chest	NN	I-NP	O
tubes	tube	NNS	I-NP	O
were	be	VBD	B-VP	O
removed	remove	VBN	I-VP	O
without	without	IN	B-PP	O
incident	incident	NN	B-NP	O
.	.	.	O	O

Post-pull	Post-pull	JJ	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
pneumothorax	pneumothorax	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
3	3	CD	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
continued	continue	VBN	B-VP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
confusion	confusion	NN	I-NP	O
requiring	require	VBG	B-VP	O
a	a	DT	B-NP	O
sitter	sitter	NN	I-NP	O
.	.	.	O	O

Psychiatry	Psychiatry	NN	B-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
and	and	CC	O	O
recommended	recommend	VBN	B-VP	O
to	to	TO	I-VP	O
restart	restart	VB	I-VP	O
his	his	PRP$	B-NP	O
preoperative	preoperative	JJ	I-NP	O
benzodiazepine	benzodiazepine	NN	I-NP	O
and	and	CC	I-NP	O
Haldol	Haldol	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
evening	evening	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Infectious	Infectious	NNP	I-NP	O
Disease	Disease	NNP	I-NP	O
Service	Service	NNP	I-NP	O
for	for	IN	B-PP	O
shingles	shingle	NNS	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
seven-day	seven-day	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
acyclovir	acyclovir	NN	B-NP	O
for	for	IN	B-PP	O
post-herpetic	post-herpetic	JJ	B-NP	O
neuralgia	neuralgia	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
required	require	VBD	B-VP	O
vigorous	vigorous	JJ	B-NP	O
diuresis	diuresis	NN	I-NP	O
and	and	CC	O	O
pulmonary	pulmonary	JJ	B-NP	O
toilet	toilet	NN	I-NP	O
with	with	IN	B-PP	O
Mucomyst	Mucomyst	NN	B-NP	O
and	and	CC	O	O
vigorous	vigorous	JJ	B-NP	O
chest	chest	NN	I-NP	O
physical	physical	JJ	I-NP	O
therapy	therapy	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
mental	mental	JJ	I-NP	O
status	status	NN	I-NP	O
cleared	clear	VBD	B-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
no	no	RB	B-ADVP	O
longer	longer	RB	I-ADVP	O
required	require	VBD	B-VP	O
a	a	DT	B-NP	O
sitter	sitter	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
screened	screen	VBN	I-VP	O
by	by	IN	B-PP	O
rehab	rehab	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
accepted	accept	VBN	I-VP	O
for	for	IN	B-PP	O
transfer	transfer	NN	B-NP	O
to	to	TO	B-VP	O
rehab	rehab	VB	I-VP	O
on	on	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
11	11	CD	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
received	receive	VBD	B-VP	O
additionally	additionally	RB	B-ADVP	O
a	a	DT	B-NP	O
unit	unit	NN	I-NP	O
of	of	IN	B-PP	O
packed	packed	JJ	B-NP	B-cell_type
red	red	JJ	I-NP	I-cell_type
blood	blood	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
for	for	IN	B-PP	O
hematocrit	hematocrit	NN	B-NP	O
of	of	IN	B-PP	O
23	23	CD	B-NP	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
result	result	NN	I-NP	O
.	.	.	O	O

Isaias	Isaias	NNP	B-NP	O
Sellars	Sellars	NNP	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Lovenox	Lovenox	NNP	B-NP	O
on	on	IN	B-PP	O
4/4/05	4/4/05	CD	B-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
bridge	bridge	NN	I-NP	O
to	to	TO	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
until	until	IN	B-PP	O
his	his	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
increases	increase	VBZ	B-VP	O
to	to	TO	B-PP	O
2.0	2.0	CD	B-NP	O
for	for	IN	B-PP	O
his	his	PRP$	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
,	,	,	O	O
atrial	atrial	JJ	B-NP	O
flutter	flutter	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
discharge	discharge	NN	I-NP	O
medications	medication	NNS	I-NP	O
for	for	IN	B-PP	O
Matt	Matt	NNP	B-NP	O
Foat	Foat	NNP	I-NP	O
is	be	VBZ	B-VP	O
as	as	IN	B-SBAR	O
follows	follow	VBZ	B-VP	O
:	:	:	O	O
Baby	Baby	NN	B-NP	O
aspirin	aspirin	NN	I-NP	O
81	81	CD	B-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Klonopin	Klonopin	NN	B-NP	O
0.5	0.5	CD	I-NP	O
mg	mg	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
evening	evening	NN	I-NP	O
,	,	,	O	O
colchicine	colchicine	NN	B-NP	O
0.6	0.6	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Lasix	Lasix	NN	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Haldol	Haldol	NN	B-NP	O
0.5	0.5	CD	I-NP	O
mg	mg	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
evening	evening	NN	I-NP	O
,	,	,	O	O
insulin	insulin	NN	B-NP	B-protein
NPH	NPH	NN	I-NP	I-protein
16	16	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
evening	evening	NN	I-NP	O
at	at	IN	B-PP	O
10	10	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
p.m.	p.m.	NN	I-NP	O
and	and	CC	O	O
20	20	CD	B-NP	O
units	unit	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
,	,	,	O	O
Lopressor	Lopressor	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
every	every	DT	B-NP	O
six	six	CD	I-NP	O
hours	hour	NNS	I-NP	O
,	,	,	O	O
Niferex	Niferex	NNP	B-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Proscar	Proscar	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Lovenox	Lovenox	NN	B-NP	O
subq	subq	NN	I-NP	O
every	every	DT	B-NP	O
12	12	CD	I-NP	O
hours	hour	NNS	I-NP	O
until	until	IN	B-PP	O
INR	INR	NN	B-NP	B-protein
reaches	reach	NNS	I-NP	I-protein
2.0	2.0	CD	B-NP	I-protein
or	or	CC	I-NP	O
greater	great	JJR	I-NP	O
,	,	,	I-NP	O
potassium	potassium	NN	I-NP	O
chloride	chloride	NN	I-NP	O
slow	slow	JJ	I-NP	O
release	release	NN	I-NP	O
20	20	CD	B-NP	O
mEq	mEq	NN	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Plavix	Plavix	NN	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Nexium	Nexium	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
DuoNebs	DuoNeb	NNS	B-NP	O
inhaler	inhaler	VBP	B-VP	O
every	every	DT	B-NP	O
two	two	CD	I-NP	O
hours	hour	NNS	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
wheezing	wheeze	VBG	B-NP	O
,	,	,	O	O
NovoLog	NovoLog	NNP	B-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
a.c.	a.c.	NN	I-NP	O
and	and	CC	O	O
q.h.s.	q.h.s.	NN	B-NP	O
,	,	,	O	O
NovoLog	NovoLog	NN	B-NP	O
insulin	insulin	NN	I-NP	O
8	8	CD	B-NP	O
units	unit	NNS	I-NP	O
with	with	IN	B-PP	O
breakfast	breakfast	NN	B-NP	O
and	and	CC	O	O
2	2	CD	B-NP	O
units	unit	NNS	I-NP	O
with	with	IN	B-PP	O
lunch	lunch	NN	B-NP	O
and	and	CC	O	O
4	4	CD	B-NP	O
units	unit	NNS	I-NP	O
with	with	IN	B-PP	O
dinner	dinner	NN	B-NP	O
,	,	,	O	O
Lipitor	Lipitor	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Coumadin	Coumadin	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
received	receive	VBD	B-VP	O
6	6	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
this	this	DT	B-NP	O
evening	evening	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
Coumadin	Coumadin	NNP	I-NP	O
dosing	dosing	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
Er	Er	NNP	B-NP	B-protein
Health	Health	NNP	I-NP	O
Anticoagulation	Anticoagulation	NNP	I-NP	O
Service	Service	NNP	I-NP	O
at	at	IN	B-PP	O
-LRB-	-LRB-	NNP	B-NP	O
204	204	CD	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
273-3408	273-3408	CD	I-NP	O
for	for	IN	B-PP	O
his	his	PRP$	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
for	for	IN	B-PP	O
target	target	NN	B-NP	O
INR	INR	NN	I-NP	O
of	of	IN	B-PP	O
2.0-3	2.0-3	CD	B-NP	O
.0	.0	CD	I-NP	O
.	.	.	O	O

Jacques	Jacques	NNP	B-NP	O
Hinton	Hinton	NNP	I-NP	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Adam	Adam	NNP	I-NP	O
Raynolds	Raynolds	NNP	I-NP	O
in	in	IN	B-PP	O
six	six	CD	B-NP	O
weeks	week	NNS	I-NP	O
and	and	CC	O	O
Dr.	Dr.	NNP	B-NP	O
Florentino	Florentino	NNP	I-NP	O
Hutzel	Hutzel	NNP	I-NP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
cardiologist	cardiologist	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
LABS	LABS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
discharge	discharge	NN	I-NP	O
labs	lab	NNS	I-NP	O
for	for	IN	B-PP	O
Craig	Craig	NNP	B-NP	O
Perper	Perper	NNP	I-NP	O
is	be	VBZ	B-VP	O
as	as	IN	B-SBAR	O
follows	follow	VBZ	B-VP	O
:	:	:	O	O
Glucose	Glucose	NN	B-NP	O
of	of	IN	B-PP	O
113	113	CD	B-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	O
of	of	IN	B-PP	O
35	35	CD	B-NP	O
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
1.3	1.3	CD	I-NP	O
,	,	,	O	O
sodium	sodium	NN	B-NP	O
139	139	CD	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
4.1	4.1	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
of	of	IN	B-PP	O
106	106	CD	B-NP	O
,	,	,	O	O
CO2	CO2	NN	B-NP	O
27	27	CD	I-NP	O
,	,	,	O	O
magnesium	magnesium	NN	B-NP	O
2.2	2.2	CD	I-NP	O
,	,	,	O	O
WBC	WBC	NNP	B-NP	O
7.67	7.67	CD	I-NP	O
,	,	,	O	O
hemoglobin	hemoglobin	NN	B-NP	B-protein
8.1	8.1	CD	I-NP	I-protein
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
25.8	25.8	CD	I-NP	I-protein
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-cell_type
of	of	IN	B-PP	O
281	281	CD	B-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
.	.	.	O	O

PT/INR	PT/INR	NN	B-NP	B-protein
19.7	19.7	CD	I-NP	I-protein
,	,	,	O	O
PT/INR	PT/INR	NN	B-NP	B-protein
of	of	IN	B-PP	O
1.7	1.7	CD	B-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
Mr.	Mr.	NNP	B-NP	O
Griesbach	Griesbach	NNP	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
Ez	Ez	NNP	B-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
in	in	IN	B-PP	O
Blo	Blo	NNP	B-NP	O
CONDITION	CONDITION	NNP	I-NP	O
ON	ON	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
discharged	discharge	VBN	I-VP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
7-8075513	7-8075513	CD	B-NP	O
EMSSten	EMSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
MIMMS	MIMMS	NNP	B-NP	O
,	,	,	O	O
DANNIE	DANNIE	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
NEITZ	NEITZ	NN	B-NP	B-protein
,	,	,	O	O
ANTONE	ANTONE	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
9866309	9866309	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
1/21/05	1/21/05	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
1/21/05	1/21/05	CD	B-NP	O

